MDS Health Group Ltd said it signed agreements to acquire Nebraska-based Harris Laboratories Inc and Montreal-based Neo-Pharm Laboratories Inc, which will more than double MDS's revenue from pharmaceutical services to about C$100 million a year.
Financial details of the deal were not disclosed.
MDS said the acquired companies will be integrated with the existing international contract research operations of MDS and managed through newly formed MDS Pharmaceuticals Service, with operations in Canada, Germany, China, Taiwan, the United States and Britain.
-- Reuters Toronto Bureau  (416) 941-8100